Generic "blend purity 98%" without per-compound breakdown this is not a research-grade COA
Insufficient intrinsic factor production, common in older adults due to age-related absorption decline, can also lead to deficiency

Research Applications Wound Healing and Tissue Repair Studies KLOW Blend provides comprehensive coverage of wound healing mechanisms: Hemostasis and Inflammatory Phase: KPV modulates early inflammatory response through NF-B inhibition BPC-157 provides tissue protection against injury-induced damage TB-500 enables immune cell and repair cell migration to wound site GHK-Cu reduces excessive inflammation while supporting antimicrobial defense Proliferation and Remodeling Phase: GHK-Cu stimulates fibroblast collagen synthesis and matrix production TB-500 enhances cellular migration, proliferation, and tissue infiltration BPC-157 promotes angiogenesis and vascular network development All components support extracellular matrix formation and organization Maturation and Remodeling Phase: GHK-Cu provides balanced MMP/TIMP expression for appropriate remodeling TB-500 reduces excessive fibrosis while maintaining structural integrity BPC-157 supports continued vascular maturation KPV supports inflammation resolution and transition to tissue homeostasis Research models include excisional wound models, incisional wound models, burn injury models, diabetic wound models, and chronic wound preparations

My view has not changed: BPC-157 lacks adequate human evidence for ulcerative colitis, Crohn's disease or "gut healing", and it should not replace established IBD treatment
We know that macrocytosis is a very, very late stage of B12 deficiency and that severely deficient patients may not present with this sign, the administration of folic acid also masks macrocytosis by normalising the size of the blood cells
Yes, research suggests that even when injected subcutaneously, BPC 157 can have profound positive effects on gut health